Regeneron (REGN) Tops Q1 EPS by 53c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $635.82 +1.13%
EPS Growth %: -15.8%
Financial Fact:
Net loss: 264.8M
Today's EPS Names:
FGPR, CRMT, REPL, More
EPS Growth %: -15.8%
Financial Fact:
Net loss: 264.8M
Today's EPS Names:
FGPR, CRMT, REPL, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $10.09, $0.53 better than the analyst estimate of $9.56. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
- Change in Nonfarm Payrolls (May) 172K vs 88K Expected, Unemployment Rate 4.3%
- 'Solstice Advanced Materials (SOLS) Remains a Top Pick'; PT Raised to $101 at BMO Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
